Voleon Capital Management’s Pfizer PFE Stock Holding History

Voleon Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$489K	Buy	20,295 +3,234	+19%	+$84.6K	0.01%	590
2026 Q1	$479K	Buy	17,061 +969	+6%	+$25.8K	0.01%	584
2025 Q4	$401K	Sell	16,092 -153,602	-91%	-$3.87M	0.01%	621
2025 Q3	$4.32M	Buy	169,694 +104,364	+160%	+$2.58M	0.11%	192
2025 Q2	$1.58M	Sell	65,330 -97,594	-60%	-$2.28M	0.09%	203
2025 Q1	$4.13M	Buy	162,924 +83,015	+104%	+$2.17M	0.32%	79
2024 Q4	$2.12M	Buy	+79,909	New	+$2.17M	0.16%	133
2021 Q1	–	Sell	-343,000	Closed	-$12.6M	–	27
2020 Q4	$12.6M	Buy	+343,000	New	+$12.6M	1.35%	27
2020 Q3	–	Sell	-716,720	Closed	-$22.2M	–	12
2020 Q2	$22.2M	Buy	+716,720	New	+$24.3M	9.32%	5
2019 Q1	–	Sell	-548,080	Closed	-$22.7M	–	51
2018 Q4	$22.7M	Buy	+548,080	New	+$22.8M	2.16%	17

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Voleon Capital Management's PFE Position: Q2 2026 in Review

Voleon Capital Management increased its Pfizer (PFE) stake by 19% in Q2 2026, buying an estimated $84.6K and bringing the position to 20,295 shares worth $489K. The position accounts for 0.01% of the portfolio, ranked #590.

Voleon Capital Management first reported a position in PFE in Q4 2018 and has held it in 10 quarters since. The position peaked at $22.7M in Q4 2018. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Voleon Capital Management held 20,295 shares of Pfizer worth $489K as of Q2 2026.
Voleon Capital Management bought 3,234 Pfizer shares in Q2 2026, an estimated $84.6K.
Pfizer made up 0.01% of Voleon Capital Management's portfolio in Q2 2026, its #590 holding.
Voleon Capital Management first reported a position in Pfizer in Q4 2018 and has held it in 10 quarters since.
Voleon Capital Management's Pfizer position peaked at $22.7M in Q4 2018.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.